Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 47

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 47
---
 shareholders to serve on the board of directors; |

| • | making recommendations to the board of directors regarding nominees for directors at the next annual general meeting; |

| • | reviewing and recommending to the board of directors for its approval the type and amount of compensation to be paid or awarded to members of the board of directors; |

| • | periodically reviewing the performance of the board of directors, including committees of the board of directors and management; |

| • | overseeing the board of directors’ committee structure and operations, including authority to delegate to subcommittees and committee reporting to the board of directors; |

| • | reviewing with the Chief Executive Officer the succession plans for our executive officers; |

| • | instituting plans or programs for the continuing education of directors and orientation of new directors, as it deems appropriate; and |

| • | periodically reviewing the processes and procedures to provide information to the board of directors and its committees. |

33

TABLE OF CONTENTS Director Nomination Process We believe that an effective board of directors should be made up of individuals who collectively provide an appropriate balance of diverse occupational and personal backgrounds and perspectives and who have a range of skills and expertise sufficient to provide guidance and oversight with respect to our strategy and operations. Our board of directors and our nominating and corporate governance committee seek individuals with backgrounds and qualities that, when combined with those of our other directors, enhance the board’s effectiveness and result in a balance of knowledge, experience, and capability. Our nominating and corporate governance committee considers candidates who are recommended by its members, by other members of the board of directors, by shareholders, and by management, as well as those identified by third-party search firms retained to assist in identifying and evaluating possible candidates. In assessing potential candidates, our board of directors and nominating and corporate governance committee will consider, among other factors, whether the candidate possesses relevant expertise to offer advice and guidance to management, has sufficient time to devote to our business and operations, demonstrates excellence in the candidate’s field; has the ability to exercise sound business judgment and is committed to represent the long-term interests of our shareholders. Shareholder Recommendations and Nominations Our nominating and corporate governance committee considers both recommendations and nominations for candidates to the board of directors from shareholders so long as such recommendations and nominations comply with our articles of association and applicable laws, including the rules and regulations of the SEC. Shareholders may recommend director nominees for consideration by the nominating and corporate governance committee by writing to our Company Secretary at c/o Immunocore Holdings plc,